IMMUNOLOGICAL INVESTIGATION OF TORQUE TENO VIRUS AMONG BLOOD DONORS IN MOSUL CITY, IRAQ

Noor Sabah Anwer; Hiyam Adil Al-Taii; Anmar A. Al-Taie

doi:10.61796/jmgcb.v2i10.1413

Authors

Noor Sabah Anwer University of Mosul, Iraq
Hiyam Adil Al-Taii University of Mosul, Iraq
Anmar A. Al-Taie
anmaraltaee1978@uomosul.edu.iq
University of Mosul, Iraq

Vol. 2 No. 10 (2025): Journal of Medical Genetics and Clinical Biology

Articles

August 26, 2025

Downloads

VIEW ARTICLE

Abstract
How to Cite
Metrics
References
License

Objective: This study aimed to detect Torque Teno virus antigens using the ELISA technique and to evaluate the immune status by measuring the levels of inflammatory cytokines, namely Tumor Necrosis Factor (TNF) and Interleukin-10 (IL-10). Method: This study was conducted on 150 blood samples collected from blood donors at the main blood bank in Mosul, Iraq. The study used an enzyme-linked immunosorbent assay (ELISA) to detect viral antigens. The immune response was assessed by measuring the levels of tumor necrosis factor-alpha (TNF-α) and interleukin-10 (IL-10). Results: the ELISA test results revealed a low prevalence of TTV antigen (9.33%), with the highest rates recorded among the oldest age group (34–41 years) at 4.67%. Novelty: The results revealed the presence of immune regulatory dysfunction in this group of patients, as they exhibited signs of both immune activation and suppression simultaneously. This underscores the importance of continuous immunological monitoring for this category of patients.

Anwer, N. S., Al-Taii, H. A., & Al-Taie , A. A. (2025). IMMUNOLOGICAL INVESTIGATION OF TORQUE TENO VIRUS AMONG BLOOD DONORS IN MOSUL CITY, IRAQ. Journal of Medical Genetics and Clinical Biology, 2(10), 440–445. https://doi.org/10.61796/jmgcb.v2i10.1413

Download Citation

S. C. Smajic, M. Becarevic, S. Klapic, F. Seletovic, and A. Sahovic, "Adverse reactions and complications in voluntary blood donors," Materia Socio-Medica, vol. 35, no. 2, p. 98, 2023.

D. Hawashin, M. D. A. J. Mahboobeh, K. Salah, R. Jayaraman, I. Yaqoob, M. Debe, and S. Ellahham, "Blockchain-based management of blood donation," IEEE Access, vol. 9, pp. 163016–163032, 2021.

E. J. Gore, L. Gard, H. G. Niesters, and C. C. Van Leer Buter, "Understanding torquetenovirus (TTV) as an immune marker," Front. Med., vol. 10, p. 1168400, 2023.

I. W. Fong, "Blood transfusion-associated infections in the twenty-first century: new challenges," Curr. Trends Concerns Infect. Dis., pp. 191–215, 2020.

C. Kyathanahalli, M. Snedden, and E. Hirsch, "Human Anelloviruses: prevalence and clinical significance during pregnancy," Front. Virol., vol. 1, p. 782886, 2021.

S. Stefani, J. Rosado, E. Vicenzi, and M. Clementi, "Torque teno virus as a marker of immune function," Clin. Microbiol. Infect., vol. 27, no. 3, pp. 441–447, 2021.

P. G. Spezia, A. Baj, F. Drago Ferrante, S. Boutahar, L. Azzi, A. Genoni, et al., "Detection of Torquetenovirus and Redondovirus DNA in saliva samples from SARS-CoV-2-positive and negative subjects," Viruses, vol. 14, no. 11, p. 2482, 2022.

D. Redondo and D. Navarro, "Torque teno virus as a surrogate marker of immune function in solid organ transplantation: a review," Transplant. Rev., vol. 36, no. 2, p. 100642, 2022.

P. G. Spezia, D. Focosi, A. Baj, F. Novazzi, F. Drago Ferrante, F. Carletti, et al., "TTV and other anelloviruses: The astonishingly widespread nature of a viral infection," 2023.

Ş. Karabörk and M. E. Koçoğlu, Torque Teno Virus, Hepatitis Infections and Hepatocellular Carcinoma. BİDGE Yayınları, p. 63, 2023.

G. H. Bai, S. C. Lin, Y. H. Hsu, and S. Y. Chen, "The human virome: viral metagenomics, relations with human diseases, and therapeutic applications," Viruses, vol. 14, no. 2, p. 278, 2022.

D. S. Mankotia and M. Irshad, "Development of an immunoassay for the detection of Torque teno virus (TTV) antibodies using the N22 expression product from TTV genotype 2," Intervirology, vol. 60, no. 5, pp. 207–216, 2017.

D. Lapa, P. Del Porto, C. Minosse, G. D’Offizi, A. Antinori, M. R. Capobianchi, et al., "Clinical relevance of torque teno virus (TTV) in HIV/HCV coinfected and HCV monoinfected patients treated with direct-acting antiviral therapy," J. Clin. Med., vol. 10, no. 10, p. 2092, 2021.

H. T. Rinonce, Y. Yano, T. Utsumi, D. S. Heriyanto, N. Anggorowati, D. I. Widasari, et al., "Prevalence and genotypic distribution of GB virus C and torque teno virus among patients undergoing hemodialysis," Mol. Med. Rep., vol. 15, no. 5, pp. 2843–2852, 2017.

A. Ali, A. Al-Nakshabandi, and G. Jassim, "Molecular detection of Torque Teno Virus in hepatitis patients," J. Infect. Public Health, vol. 14, no. 4, pp. 551–555, 2021.

A. T. Al-Bayti and L. G. Alsaadi, "Detection of Torque Teno virus in Iraqi hemodialysis patients by ELISA," 2023.

I. A. Radwan, D. Rady, M. Ramadan, and S. El Moshy, "Mechanism underlying the anti-diabetic potential of bee venom as compared to bone marrow mesenchymal stem cells in the diabetic rat tongue," Dent. Med. Probl., vol. 61, no. 1, pp. 53–64, 2024.

D. Focosi, G. Antonelli, M. Pistello, and F. Maggi, "Torquetenovirus: the human virome from bench to bedside," Clin. Microbiol. Infect., vol. 22, no. 7, pp. 589–593, 2016.

F. Mallet, L. Diouf, B. Meunier, M. Perret, F. Reynier, P. Leissner, et al., "Herpes DNAemia and TTV viraemia in intensive care unit critically ill patients: a single-centre prospective longitudinal study," Front. Immunol., vol. 12, p. 698808, 2021.

I. Görzer, F. Gelas, F. Haupenthal, D. Kulifaj, E. Puchhammer-Stöckl, and G. Bond, "Validation of the optimal Torque Teno Virus range for risk stratification of graft rejection and infection in kidney transplant recipients by TTV R-GENE®," Nephrol. Dial. Transplant., vol. 37, no. Suppl. 3, pp. gfac121–002, 2022.